Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

72.48USD
9 Dec 2016
Change (% chg)

$1.73 (+2.45%)
Prev Close
$70.75
Open
$72.30
Day's High
$72.48
Day's Low
$71.51
Volume
7,403,945
Avg. Vol
3,933,837
52-wk High
$89.00
52-wk Low
$64.46

ESRX.O

Chart for ESRX.O

About

Express Scripts Holding Company is a pharmacy benefit management (PBM) company in the United States. The Company is engaged in providing healthcare management and administration services. Its segments include PBM and Other Business Operations. The PBM segment includes its integrated PBM operations and specialty pharmacy... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $44,692.69
Shares Outstanding(Mil.): 616.62
Dividend: --
Yield (%): --

Financials

  ESRX.O Industry Sector
P/E (TTM): 17.14 19.06 40.35
EPS (TTM): 4.23 -- --
ROI: 7.80 11.48 59.39
ROE: 17.07 13.04 67.12

Short-seller Citron calls Express Scripts drug price culprit

Short seller Citron Research's Andrew Left has turned his sights on Express Scripts Holding Co, calling the pharmacy benefit manager (PBM) the "culprit behind pharmaceutical price gouging."

Dec 08 2016

Fitch Assigns First-Time 'BB-' Rating to MedImpact; Outlook Positive

(The following statement was released by the rating agency) CHICAGO, November 18 (Fitch) Fitch Ratings has assigned a 'BB-' Issuer Default Rating to MedImpact Holdings, Inc. and its issuing subsidiary, MI OpCo Holdings, Inc. The Rating Outlook is Positive. A full list of rating actions follows at the end of this release. KEY RATING DRIVERS Smaller Scale in Consolidated Industry: MedImpact is a top-5 pharmacy benefit manager (PBM) but is significantly smaller than its three largest competitor

Nov 18 2016

BRIEF-Express Scripts announces receipt of letter from internal revenue service

* Says on October 28, 2016, announced receipt of a letter from internal revenue service

Oct 28 2016

Express Scripts gets subpoenas over drug company, pharmacy ties

Oct 25 Pharmacy benefit manager Express Scripts Holding Co has received subpoenas requesting information about its relationship with pharmaceutical companies, charitable foundations and specialty pharmacies, the company said in a regulatory filing on Tuesday.

Oct 25 2016

BRIEF-Express Scripts Q3 earnings per share $1.15

* Narrowed its 2016 earnings per diluted share guidance from a range of $4.45 to $4.55 to a range of $4.47 to $4.53

Oct 25 2016

Horizon Pharma to pay Express Scripts $65 million to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Sep 29 2016

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Sep 29 2016

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Sept 29 Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Sep 29 2016

BRIEF-Horizon Pharma says unit enters into settlement deal with Express Scripts - SEC filing

* On Sept 26, Horizon Pharma USA entered settlement agreement and mutual release with Express Scripts to settle litigation - SEC filing

Sep 29 2016

UnitedHealth trims drug coverage, including Sanofi insulin

UnitedHealth Group , the largest U.S. health insurer, will stop covering several brand-name drugs as of next year, reinforcing a trend of payers steering prescriptions to lower-priced options.

Sep 22 2016

Competitors

Earnings vs. Estimates